Table 2.
Methodological quality score | ||||
---|---|---|---|---|
Domains of possible interest | IMLB | DL | MAL | |
1 | Study question | |||
2 | Population | x | x | |
3 | Sample size and power calculations a priori | |||
4 | Treatment allocation | x | x | x |
5 | Study design | x | ||
6 | Ethics | |||
7 | Intervention | x | ||
8 | Outcome measures | x | x | |
9 | Follow-up/withdrawals | x | x | |
10 | Blinding | x | x | x |
11 | Cointerventions | x | ||
12 | Side-effects | x | ||
13 | Compliance | x | ||
14 | Prognostic comparability | |||
15 | Analysis | x | x | |
16 | Conclusion | |||
17 | Presentation |